PRIVATE PAYERS AND MEDICARE contractors are taking divergent approaches to establishing coverage policies and setting prices for molecular and genetic tests. That’s what Kuo Bianchini Tong, MS, CEO of Quorum Consulting Inc., sees happening. “One approach seeks to recognize the clinical utility and value of these tests with nuanced, more discreet coding and pricing,” he […]
- Payer Update
Payers Using Two Approaches To Price Molecular, Genetic Tests
One is nuanced, sophisticated, the other is more about lower prices for genetic tests
- By Joseph Burns
- > From the Volume XXIII No. 3 - February 29, 2016 Issue
- Tags: apf, cap, clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory test, clinical laboratory tests, cpt, cpt code, Diagnostic tests, ehi, genetic test, genetic tests, hie, lab consultant, lab consultants, lab industry, lab test, lab tests, laboratories, laboratory test, laboratory tests, ldt, Medicare, Medicare Administrative Contractor, MolDx, private payer
